2018 American Transplant Congress
Two Years of the HOPE Act
1United Network for Organ Sharing, Richmond, VA; 2Johns Hopkins University, Baltimore, MD.
The HOPE Act allows research on transplantation of organs from HIV+ donors into patients infected with HIV prior to transplantation. There are 42 kidney and…2018 American Transplant Congress
Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States
Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA.
Background: Ongoing organ shortage and regional differences in organ availability have encouraged patients in need of liver transplantation (LT) to travel in order to increase…2018 American Transplant Congress
Impact of Direct Acting Antivirals of Hepatitis C Virus Therapy on Tacrolimus Dosing Post-Liver Transplant
Michigan Medicine, Ann Arbor, MI.
Background: Direct acting antivirals (DAA) have transformed hepatitis C virus (HCV) management post-liver transplant (LT). As HCV clears, hepatic metabolism improves, resulting in decreased tacrolimus…2018 American Transplant Congress
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015
Background: There are no population-based estimates of the prevalence of end-stage liver disease in the United States, creating challenges in measuring disease burden to inform…2018 American Transplant Congress
HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation
PURPOSE: The phenomenon of graft versus host disease after orthotopic liver transplantation (OLT) is estimated at approximately 1-2%, suggesting that under some circumstances, the graft…2018 American Transplant Congress
Hyaluronic Acid as Early Biomarker of Graft Loss after Liver Transplantation: A Prospective Study
Introduction: Improved diagnosis and understanding the pathophysiology of early allograft dysfunction is essential to improve the short-term outcome after liver transplantation (LT). Hyaluronic acid (HA)…2018 American Transplant Congress
Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis
Organ Transplant Center, Sun yat-sen University, Guangzhou, China.
Background. Splenectomy is performed as strategy of modulating the portal vein pressure in most of portal hypertension patients with liver cirrhosis. In liver transplantation, researchers…2018 American Transplant Congress
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients
Abdominal Transplant Surgery, Oregon Health & Science University, Portland, OR.
Background: Concern for inferior outcomes in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) have limited utilization of donation after cardiac death…2018 American Transplant Congress
Financial Impact of Testing Standardization for Solid Organ Transplant Recipients
Background: Infection and bone marrow suppression surveillance is common practice in transplant recipients. Ordering of inappropriate lab tests can lead to repetitive blood draws, higher…2018 American Transplant Congress
Liver Transplantation for Hepatocellular Carcinoma Outperform Other Populations in the New Hepatitis C Era
Background: Long term results of HCC liver transplants (LTx) in the recent era of direct-acting antivirals (DAA) against hepatitis C (HCV) are not available. We…
- « Previous Page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- …
- 180
- Next Page »